Objective 1:  
Adopt and/or strengthen control measures to prevent diversion towards illicit activities of pharmaceutical products containing precursors substances or those containing narcotic drugs and/or psychotropic substances, ensuring the adequate availability and access solely for medical and scientific purposes.
 

Objective 2:  
Establish, update and strengthen, as appropriate, the legislative and institutional frameworks to counter money laundering derived from drug trafficking.
 

Objective 3:  
Strengthen agencies for the administration and disputation of seized and forfeited assets as proceeds of crime in cases of drug trafficking.